 | |
- close
- close
|
TheStreet.com
Dec 2
Comment
Several stocks trading near $5 were moving on above-average volume during Wednesday's session.
Market Intelligence Center
Dec 2
Comment
Geron (GERN) leads the list of top gainers so far today after the U.S. government approved the first 13 new batches of human embryonic stem cells. GERN is one of several biotech companies pursuing stem cell research. The stock is now at $6.03, up...
StreetInsider.com
Dec 2
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/NIH+Approves+13+Stem-Cell+Lines+for+Research%3B+Watch+STEM%2C+ASTM%2C+PSTI%2C+CYTX%2C+GERN+on+the+News/5153426.html for the full story.
Business Wire
Nov 16
Comment
Geron Corporation (Nasdaq:GERN) today announced that Thomas B. Okarma, Ph.D., M.D., president and chief executive officer, will present an update of the company’s product development programs at 11:30 a.m. ET on Wednesday, November 18, 2009, at the
Business Wire
Nov 11
Comment
Geron Corporation (Nasdaq:GERN) today announced the publication of data showing that oligodendrocyte progenitor cells (OPCs) derived from human embryonic stem cells (hESCs), when transplanted into a rodent model of cervical spinal cord injury,
Market Intelligence Center
Oct 30
Comment
Geron (NGM: GERN) opened at $6.04. So far today, the stock has hit a low of $5.86 and a high of $6.49. GERN is now trading at $6.05, up $0.28 (4.85%). The stock hit its 52-Week high of $9.24 in July and set its 52-Week low of $2.48 in November. ...
Business Wire
Oct 30
Comment
Geron Corporation (Nasdaq: GERN) today announced the company’s plan to advance clinical development of its human embryonic stem cell (hESC)-based product, GRNOPC1, for the treatment of spinal cord injury. The plan is expected to enable Geron to
Business Wire
Oct 29
Comment
Geron Corporation (Nasdaq:GERN) today reported financial results for the three and nine months ended September 30, 2009. For the third quarter of 2009, the company reported net loss applicable to common stockholders of $15.2 million, or $(0.17) per
|
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
|
||
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
GERN AT A GLANCE
References
| ||||||
|
|
